Morgan Stanley Boosts Colgate Target to $100 as Shares Rise 22% YTD
Colgate-Palmolive shares have climbed 10.5% year-over-year and 22% year-to-date on fourth-quarter organic sales growth and margin improvement. Morgan Stanley raised its price target to $100 from $87 with an Overweight rating, and Evercore ISI raised its target to $100, citing gains in oral care and pet nutrition segments.
1. Share Performance and Q4 Results
Colgate-Palmolive Company has seen its share price rise 10.5% year-over-year and 22% year-to-date following a fourth-quarter organic sales growth of 2% and margin improvement driven by lower currency pressures.
2. Morgan Stanley Upgrade
Morgan Stanley raised its price target to $100 from $87 with an Overweight rating after highlighting the company’s strong organic sales growth and expanding margins in the latest quarter.
3. Evercore ISI Upgrade
Evercore ISI increased its price target to $100 from $94, noting that Colgate-Palmolive gained market share in key segments such as oral care and pet nutrition.
4. Jim Cramer Commentary
Jim Cramer pointed to Colgate-Palmolive as an example of consistent execution, emphasizing that the company achieved 2% growth versus 1% in the prior quarter, demonstrating reliable performance rather than rapid expansion.